Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: Jul 31, 2026, 4:00 PM EDT
1.060
+0.050 (4.95%)
Pre-market: Aug 3, 2026, 7:47 AM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $2.3 million as of August 3, 2026. Its market cap has decreased by -98.08% in one year.
Market Cap
2.30M
Enterprise Value
2.43M
1-Year Change
-98.08%
Ranking
Category
Stock Price
$1.01
ChartMarket Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $2.30M, an increase of 302.70%. That is a compound annual growth rate of 49.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.30M | -67.91% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 2.68M |
| Clearmind Medicine | 2.51M |
| Creative Medical Technology Holdings | 2.45M |
| GRI Bio | 2.44M |
| Oragenics | 2.26M |
| Decoy Therapeutics | 2.19M |
| Azitra | 2.15M |
| Moleculin Biotech | 2.13M |